The genetics of mitochondrial disease

Seminars in Neurology

Volumn 31, Issue 5, 2011, Pages 519-530

  Davis, Ryan L ^a   Sue, Carolyn M ^a  

^a ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

mitochondria; Mitochondrial disease; mitochondrial DNA; nuclear DNA encoded mitochondrial disease

Indexed keywords

ADENOSINE TRIPHOSPHATE; CELL NUCLEUS DNA; MITOCHONDRIAL DNA;

ARTICLE; CLINICAL FEATURE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; GENETIC VARIABILITY; GENETICS; HETEROPLASMY; HUMAN; KEARNS SAYRE SYNDROME; LEBER HEREDITARY OPTIC NEUROPATHY; LEIGH DISEASE; MELAS SYNDROME; MERRF SYNDROME; MITOCHONDRIAL MEMBRANE; MITOCHONDRION; MNGIE SYNDROME; PHENOTYPE; POINT MUTATION; PRIORITY JOURNAL;

DNA; DNA, MITOCHONDRIAL; ELECTRON TRANSPORT; HUMANS; KEARNS-SAYRE SYNDROME; LEIGH DISEASE; MELAS SYNDROME; MERRF SYNDROME; MITOCHONDRIA; MITOCHONDRIAL DISEASES; MUTATION; OPTIC ATROPHY, HEREDITARY, LEBER;

EID: 84856171309     PISSN: 02718235     EISSN: 10989021     Source Type: Journal    
DOI: 10.1055/s-0031-1299790     Document Type: Article

References (71)

1. Anderson S, Bankier A T., Barrell B G. et al. Sequence and organization of the human mitochondrial genome. Nature 1981 290 5806 457-465 (Pubitemid 11159074)
2. Sue C M. Mitochondrial disease: recognising more than just the tip of the iceberg. Med J Aust 2010 193 4 195-196
3. Luft R, Ikkos D, Palmieri G, Ernster L, Afzelius B. A case of severe hypermetabolism of nonthyroid origin with a defect in the maintenance of mitochondrial respiratory control: a correlated clinical, biochemical, and morphological study. J Clin Invest 1962 41 9 1776-1804
4. DiMauro S, Bonilla E, Lee C P. et al. Luft's disease. Further biochemical and ultrastructural studies of skeletal muscle in the second case. J Neurol Sci 1976 27 2 217-232
5. Engel W K., Cunningham G G. Rapid examination of muscle tissue. An improved trichrome method for fresh-frozen biopsy sections. Neurology 1963 13 919-923
6. Shy G M., Gonatas N K. Human myopathy with giant abnormal mitochondria. Science 1964 145 3631 493-496
7. Shy G M., Gonatas N K., Perez M. Two childhood myopathies with abnormal mitochondria. I. Megaconial myopathy. II. Pleoconial myopathy. Brain 1966 89 1 133-158
8. Holt I J., Harding A E., Morgan-Hughes J A. Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies. Nature 1988 331 6158 717-719 (Pubitemid 18062238)
9. Wallace D C., Singh G, Lott M T. et al. Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. Science 1988 242 4884 1427-1430 (Pubitemid 19008070)
10. Ruiz-Pesini E, Lott M T., Procaccio V et al. An enhanced MITOMAP with a global mtDNA mutational phylogeny. Nucleic Acids Res 2007 35 Suppl 1 D823-D828 (Pubitemid 46056316)
11. Schwartz M, Vissing J. Paternal inheritance of mitochondrial DNA. N Engl J Med 2002 347 8 576-580
12. Chomyn A, Meola G, Bresolin N, Lai S T., Scarlato G, Attardi G. In vitro genetic transfer of protein synthesis and respiration defects to mitochondrial DNA-less cells with myopathy-patient mitochondria. Mol Cell Biol 1991 11 4 2236-2244 (Pubitemid 21895596)
13. Petruzzella V, Moraes C T., Sano M C., Bonilla E, DiMauro S, Schon E A. Extremely high levels of mutant mtDNAs co-localize with cytochrome c oxidase-negative ragged-red fibers in patients harboring a point mutation at nt 3243. Hum Mol Genet 1994 3 3 449-454 (Pubitemid 24083906)
14. DiMauro S. Mitochondrial encephalomyopathies. In: Rosenberg R N. Prusiner S B. DiMauro S Barchi R L. eds. The Molecular and Genetic Basis of Neurological Disease. Boston, MA Butterworth-Heinemann 1993 665-694
15. Hammans S R., Sweeney M G., Brockington M et al. The mitochondrial DNA transfer RNA(Lys)A>G(8344) mutation and the syndrome of myoclonic epilepsy with ragged red fibres (MERRF). Relationship of clinical phenotype to proportion of mutant mitochondrial DNA. Brain 1993 116 Pt 3 617-632 (Pubitemid 23203641)
16. Hammans S R., Sweeney M G., Hanna M G., Brockington M, Morgan-Hughes J A., Harding A E. The mitochondrial DNA transfer RNALeu(UUR) A>G(3243) mutation. A clinical and genetic study. Brain 1995 118 Pt 3 721-734
17. Sue C M., Bruno C, Andreu A L. et al. Infantile encephalopathy associated with the MELAS A3243G mutation. J Pediatr 1999 134 6 696-700 (Pubitemid 30186811)
18. Chinnery P F., Taylor D J., Brown D T., Manners D, Styles P, Lodi R. Very low levels of the mtDNA A3243G mutation associated with mitochondrial dysfunction in vivo. Ann Neurol 2000 47 3 381-384 (Pubitemid 30141851)
19. Schon E A., Rizzuto R, Moraes C T., Nakase H, Zeviani M, DiMauro S. A direct repeat is a hotspot for large-scale deletion of human mitochondrial DNA. Science 1989 244 4902 346-349 (Pubitemid 19117872)
20. Rocher C, Letellier T, Copeland W C., Lestienne P. Base composition at mtDNA boundaries suggests a DNA triple helix model for human mitochondrial DNA large-scale rearrangements. Mol Genet Metab 2002 76 2 123-132 (Pubitemid 34757135)
21. Shanske S, Tang Y, Hirano M et al. Identical mitochondrial DNA deletion in a woman with ocular myopathy and in her son with Pearson syndrome. Am J Hum Genet 2002 71 3 679-683 (Pubitemid 34970141)
22. Poulton J, Deadman M E., Gardiner R M. Duplications of mitochondrial DNA in mitochondrial myopathy. Lancet 1989 1 8632 236-240 (Pubitemid 19045468)
23. Poulton J, Deadman M E., Bindoff L, Morten K, Land J, Brown G. Families of mtDNA re-arrangements can be detected in patients with mtDNA deletions: duplications may be a transient intermediate form. Hum Mol Genet 1993 2 1 23-30 (Pubitemid 23060743)
24. Zeviani M, Servidei S, Gellera C, Bertini E, DiMauro S, DiDonato S. An autosomal dominant disorder with multiple deletions of mitochondrial DNA starting at the D-loop region. Nature 1989 339 6222 309-311 (Pubitemid 19130698)
25. Zeviani M, Bresolin N, Gellera C et al. Nucleus-driven multiple large-scale deletions of the human mitochondrial genome: a new autosomal dominant disease. Am J Hum Genet 1990 47 6 904-914 (Pubitemid 120024058)
26. Moraes C T., DiMauro S, Zeviani M et al. Mitochondrial DNA deletions in progressive external ophthalmoplegia and Kearns-Sayre syndrome. N Engl J Med 1989 320 20 1293-1299 (Pubitemid 19140403)
27. Tengan C H., Moraes C T. Detection and analysis of mitochondrial DNA deletions by whole genome PCR. Biochem Mol Med 1996 58 1 130-134 (Pubitemid 26235230)
28. He L, Chinnery P F., Durham S E. et al. Detection and quantification of mitochondrial DNA deletions in individual cells by real-time PCR. Nucleic Acids Res 2002 30 14 e68
29. Sue C M., Quigley A, Katsabanis S et al. Detection of MELAS A3243G point mutation in muscle, blood and hair follicles. J Neurol Sci 1998 161 1 36-39 (Pubitemid 28559181)
30. Pavlakis S G., Phillips P C., DiMauro S, De Vivo D C., Rowland L P. Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes: a distinctive clinical syndrome. Ann Neurol 1984 16 4 481-488 (Pubitemid 14021826)
31. Goto Y, Nonaka I, Horai S. A mutation in the tRNA(Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature 1990 348 6302 651-653 (Pubitemid 120015131)
32. Goto Y. Clinical features of MELAS and mitochondrial DNA mutations. Muscle Nerve 1995 3 12 S107-S112
33. Sue C M., Crimmins D S., Soo Y S. et al. Neuroradiological features of six kindreds with MELAS tRNA(Leu) A2343G point mutation: implications for pathogenesis. J Neurol Neurosurg Psychiatry 1998 65 2 233-240
34. Sue C M., Lipsett L J., Crimmins D S. et al. Cochlear origin of hearing loss in MELAS syndrome. Ann Neurol 1998 43 3 350-359 (Pubitemid 28113598)
35. Kadowaki T, Kadowaki H, Mori Y et al. A subtype of diabetes mellitus associated with a mutation of mitochondrial DNA. N Engl J Med 1994 330 14 962-968 (Pubitemid 24103594)
36. van den Ouweland J M., Lemkes H H., Trembath R C. et al. Maternally inherited diabetes and deafness is a distinct subtype of diabetes and associates with a single point mutation in the mitochondrial tRNA(Leu)(UUR) gene. Diabetes 1994 43 6 746-751
37. Moraes C T., Ciacci F, Silvestri G et al. Atypical clinical presentations associated with the MELAS mutation at position 3243 of human mitochondrial DNA. Neuromuscul Disord 1993 3 1 43-50 (Pubitemid 23186180)
38. Johns D R., Stein A G., Wityk R. MELAS syndrome masquerading as herpes simplex encephalitis. Neurology 1993 43 12 2471-2473 (Pubitemid 24004529)
39. Crimmins D, Morris J G., Walker G L. et al. Mitochondrial encephalomyopathy: variable clinical expression within a single kindred. J Neurol Neurosurg Psychiatry 1993 56 8 900-905 (Pubitemid 23246152)
40. Fukuhara N, Tokiguchi S, Shirakawa K, Tsubaki T. Myoclonus epilepsy associated with ragged-red fibres (mitochondrial abnormalities): disease entity or a syndrome? Light-and electron-microscopic studies of two cases and review of literature. J Neurol Sci 1980 47 1 117-133 (Pubitemid 10082950)
41. Shoffner J M., Lott M T., Lezza AMS, Seibel P, Ballinger S W., Wallace D C. Myoclonic epilepsy and ragged-red fiber disease (MERRF) is associated with a mitochondrial DNA tRNA(Lys) mutation. Cell 1990 61 6 931-937
42. Tatuch Y, Christodoulou J, Feigenbaum A et al. Heteroplasmic mtDNA mutation (T - - G) at 8993 can cause Leigh disease when the percentage of abnormal mtDNA is high. Am J Hum Genet 1992 50 4 852-858
43. Kirby D M., Boneh A, Chow C W. et al. Low mutant load of mitochondrial DNA G13513A mutation can cause Leigh's disease. Ann Neurol 2003 54 4 473-478 (Pubitemid 37176542)
44. Sarzi E, Brown M D., Lebon S et al. A novel recurrent mitochondrial DNA mutation in ND3 gene is associated with isolated complex I deficiency causing Leigh syndrome and dystonia. Am J Med Genet A 2007 143 1 33-41 (Pubitemid 46051469)
45. Man PYW, Turnbull D M., Chinnery P F. Leber hereditary optic neuropathy. J Med Genet 2002 39 3 162-169 (Pubitemid 34252551)
46. Jun A S., Trounce I A., Brown M D., Shoffner J M., Wallace D C. Use of transmitochondrial cybrids to assign a complex I defect to the mitochondrial DNA-encoded NADH dehydrogenase subunit 6 gene mutation at nucleotide pair 14459 that causes Leber hereditary optic neuropathy and dystonia. Mol Cell Biol 1996 16 3 771-777
47. Manwaring N, Jones M M., Wang J J. et al. Population prevalence of the MELAS A3243G mutation. Mitochondrion 2007 7 3 230-233 (Pubitemid 46420125)
48. Vandebona H, Mitchell P, Manwaring N et al. Prevalence of mitochondrial 1555A>G mutation in adults of European descent. N Engl J Med 2009 360 6 642-644
49. Spinazzola A, Zeviani M. Disorders of nuclear-mitochondrial intergenomic signaling. Gene 2005 354 162-168 (Pubitemid 41116697)
50. Pagliarini D J., Calvo S E., Chang B et al. A mitochondrial protein compendium elucidates complex I disease biology. Cell 2008 134 1 112-123 (Pubitemid 351916708)
51. Koene S, Smeitink J. Mitochondrial medicine: entering the era of treatment. J Intern Med 2009 265 2 193-209
52. Wong L-JC. Molecular genetics of mitochondrial disorders. Dev Disabil Res Rev 2010 16 2 154-162
53. Quinzii C M., Kattah A G., Naini A et al. Coenzyme Q deficiency and cerebellar ataxia associated with an aprataxin mutation. Neurology 2005 64 3 539-541 (Pubitemid 40189878)
54. Mollet J, Giurgea I, Schlemmer D et al. Prenyldiphosphate synthase, subunit 1 (PDSS1) and OH-benzoate polyprenyltransferase (COQ2) mutations in ubiquinone deficiency and oxidative phosphorylation disorders. J Clin Invest 2007 117 3 765-772 (Pubitemid 46348535)
55. Lagier-Tourenne C, Tazir M, Lpez L C. et al. ADCK3, an ancestral kinase, is mutated in a form of recessive ataxia associated with coenzyme Q10 deficiency. Am J Hum Genet 2008 82 3 661-672 (Pubitemid 351735958)
56. Mollet J, Delahodde A, Serre V et al. CABC1 gene mutations cause ubiquinone deficiency with cerebellar ataxia and seizures. Am J Hum Genet 2008 82 3 623-630 (Pubitemid 351735957)
57. Quinzii C, Naini A, Salviati L et al. A mutation in para-hydroxybenzoate- polyprenyl transferase (COQ2) causes primary coenzyme Q10 deficiency. Am J Hum Genet 2006 78 2 345-349 (Pubitemid 43157573)
58. Gempel K, Topaloglu H, Talim B et al. The myopathic form of coenzyme Q10 deficiency is caused by mutations in the electron-transferring-flavoprotein dehydrogenase (ETFDH) gene. Brain 2007 130 Pt 8 2037-2044 (Pubitemid 47236610)
59. Nishino I, Spinazzola A, Hirano M. Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder. Science 1999 283 5402 689-692
60. Hirano M, Lagier-Tourenne C, Valentino M L., Mart R, Nishigaki Y. Thymidine phosphorylase mutations cause instability of mitochondrial DNA. Gene 2005 354 152-156 (Pubitemid 41116695)
61. Hirano M, Mart R, Casali C et al. Allogeneic stem cell transplantation corrects biochemical derangements in MNGIE. Neurology 2006 67 8 1458-1460 (Pubitemid 44632073)
62. DiMauro S, Hirano M, Kaufmann P, Mann J J. Mitochondrial psychiatry. In: DiMauro S Hirano M Schon E eds. Mitochondrial Medicine. London Informa Healthcare 2006 261-277
63. Horvath R, Hudson G, Ferrari G et al. Phenotypic spectrum associated with mutations of the mitochondrial polymerase gamma gene. Brain 2006 129 Pt 7 1674-1684 (Pubitemid 43999402)
64. Longley M J., Clark S, Yu Wai Man C et al. Mutant POLG2 disrupts DNA polymerase gamma subunits and causes progressive external ophthalmoplegia. Am J Hum Genet 2006 78 6 1026-1034 (Pubitemid 43787693)
65. Barth P G., Wanders R J., Vreken P, Janssen E A., Lam J, Baas F. X-linked cardioskeletal myopathy and neutropenia (Barth syndrome) (MIM 302060). J Inherit Metab Dis 1999 22 4 555-567 (Pubitemid 29281043)
66. Bossy-Wetzel E, Barsoum M J., Godzik A, Schwarzenbacher R, Lipton S A. Mitochondrial fission in apoptosis, neurodegeneration and aging. Curr Opin Cell Biol 2003 15 6 706-716 (Pubitemid 37487964)
67. Fichera M, Lo Giudice M, Falco M et al. Evidence of kinesin heavy chain (KIF5A) involvement in pure hereditary spastic paraplegia. Neurology 2004 63 6 1108-1110 (Pubitemid 39287929)
68. Delettre C, Lenaers G, Griffoin J-M et al. Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy. Nat Genet 2000 26 2 207-210
69. Züchner S, Mersiyanova I V., Muglia M et al. Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A. Nat Genet 2004 36 5 449-451 (Pubitemid 38620027)
70. Lawson V H., Graham B V., Flanigan K M. Clinical and electrophysiologic features of CMT2A with mutations in the mitofusin 2 gene. Neurology 2005 65 2 197-204 (Pubitemid 41022361)
71. Züchner S, De Jonghe P, Jordanova A et al. Axonal neuropathy with optic atrophy is caused by mutations in mitofusin 2. Ann Neurol 2006 59 2 276-281 (Pubitemid 43202480)